Legal Representation
Attorney
Janina Gorbach
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 4, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Aug 4, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 31, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 19, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 19, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 13, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 12, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 24, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 24, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 24, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 24, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jul 24, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 24, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 24, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 17, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 17, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 17, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 6, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 9, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 3, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
A full line of over the counter medicated preparations for use in the treatment of cold and flu, pain, allergy, gastrointestinal and respiratory disorders and a full line of pharmaceutical preparations for use in connection with humans; pharmaceutical preparations for the treatment of respiratory, infectious and viral diseases and disorders; cough suppressant in the nature of cough syrups, cough drops, and anti-cough drops; cold medicines in the nature of preparations for treating colds; cold and sinus medicines in the nature of pharmaceutical preparations for the treatment of sinus congestion; analgesic preparations; dietary and nutritional supplements; Diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Covid-19, Influenza A, Influenza B and Respiratory Syncytial virus
Additional Information
Pseudo Mark
PFIZER THREE SIX ZERO; PFIZER THREE HUNDRED SIXTY
Classification
International Classes
005